Avadel Pharmaceuticals plc received an amended Schedule 13G/A from investment entities associated with Jeffrey L. Gendell, reporting a reduced ownership position below the 5% threshold. This amendment is described as an exit filing for the reporting persons.
Mr. Gendell reports beneficial ownership of 4,839,357 American Depositary Shares, or 4.9% of Avadel’s ordinary shares outstanding. Within this total, Tontine Capital Overseas Master Fund II, L.P. and Tontine Asset Associates, LLC each report beneficial ownership of 2,859,475 American Depositary Shares, or approximately 2.9% of the outstanding ordinary shares.
Positive
None.
Negative
None.
Insights
Key Avadel holder now reports a 4.9% stake, triggering an exit-type ownership filing.
Investment entities linked to Jeffrey L. Gendell report beneficial ownership of 4,839,357 Avadel American Depositary Shares, equal to 4.9% of ordinary shares outstanding. This falls below the 5% reporting threshold, and the amendment is characterized as an exit filing for the reporting group.
Within this structure, Tontine Capital Overseas Master Fund II, L.P. and Tontine Asset Associates, LLC each report 2,859,475 American Depositary Shares, or about 2.9% of the ordinary shares, based on 98,153,471 shares outstanding as of November 25, 2025. The certification states the holdings are not for changing or influencing control.
The filing signals that these investors currently remain significant but non‑5% holders. Future ownership updates, if any, would be reflected in subsequent beneficial ownership reports should their stake again cross relevant regulatory thresholds.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 3)
Avadel Pharmaceuticals plc
(Name of Issuer)
American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share
(Title of Class of Securities)
05337M104
(CUSIP Number)
12/31/2025
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
SCHEDULE 13G
CUSIP No.
05337M104
1
Names of Reporting Persons
Tontine Asset Associates, LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
2,859,475.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
2,859,475.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
2,859,475.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
2.9 %
12
Type of Reporting Person (See Instructions)
OO
Comment for Type of Reporting Person: The percentages used in this Schedule 13G/A are calculated based upon the 98,153,471 ordinary shares, nominal value $0.01 per share, of Avadel Pharmaceuticals plc (the "Company") issued and outstanding at November 25, 2025, as set forth in the Company's definitive proxy statement filed with the Securities and Exchange Commission on December 3, 2025.
This Amendment No. 3 is being filed to report that the Reporting Persons (defined below) no longer beneficially own more than five percent of the outstanding ordinary shares of the Company. This Amendment No. 3 constitutes an exit filing for the Reporting Persons.
SCHEDULE 13G
CUSIP No.
05337M104
1
Names of Reporting Persons
Tontine Capital Overseas Master Fund II, L.P.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
2,859,475.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
2,859,475.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
2,859,475.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
2.9 %
12
Type of Reporting Person (See Instructions)
PN
SCHEDULE 13G
CUSIP No.
05337M104
1
Names of Reporting Persons
Jeffrey L. Gendell
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
70,000.00
6
Shared Voting Power
4,769,357.00
7
Sole Dispositive Power
70,000.00
8
Shared Dispositive Power
4,769,357.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
4,839,357.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
4.9 %
12
Type of Reporting Person (See Instructions)
IN
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
Avadel Pharmaceuticals plc
(b)
Address of issuer's principal executive offices:
The Company's principal executive offices are located at 10 Earlsfort Terrace, Dublin 2, D02 T380, Ireland.
Item 2.
(a)
Name of person filing:
This statement is filed by:
(i) Tontine Capital Overseas Master Fund II, L.P. ("TCOM II"), a limited partnership organized under the laws of the State of Delaware, with respect to 2,859,475 American Depositary Shares directly owned by TCOM II;
(ii) Tontine Asset Associates, LLC, a limited liability company organized under the laws of the State of Delaware ("TAA"), which serves as general partner of TCOM II, with respect to the American Depositary Shares directly owned by TCOM II; and
(iii) Jeffrey L. Gendell, a United States citizen ("Mr. Gendell"), with respect to 2,859,475 American Depositary Shares directly owned by TCOM II,
1,909,882 American Depositary Shares directly owned by Tontine Financial Partners, L.P., a limited partnership organized under the laws of the State of Delaware ("TFP"), and 70,000 American Depositary Shares directly owned by Mr. Gendell. Mr. Gendell serves as the Managing Member of TAA and also serves as the Managing Member of Tontine Management, L.L.C., a limited liability company organized under the laws of the State of Delaware ("TM"), which serves as general partner of TFP.
The foregoing persons are hereinafter sometimes collectively referred to as the "Reporting Persons." Any disclosures herein with respect to persons other than the Reporting Persons are made on information and belief after making inquiry to the appropriate party.
(b)
Address or principal business office or, if none, residence:
The address of the business office of each of the Reporting Persons is 1 Sound Shore Drive, Suite 304, Greenwich, CT 06830-7251.
(c)
Citizenship:
See Item 2(a) above.
(d)
Title of class of securities:
American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share
(e)
CUSIP No.:
05337M104
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
4,839,357
(b)
Percent of class:
4.9 %
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
70,000
(ii) Shared power to vote or to direct the vote:
4,769,357
(iii) Sole power to dispose or to direct the disposition of:
70,000
(iv) Shared power to dispose or to direct the disposition of:
4,769,357
The amounts and percentage set forth above in this Item 4 reflect the beneficial ownership of Mr. Gendell. TAA and TCOM II each beneficially own, and have shared voting and dispositive power over, 2,859,475 American Depositary Shares, or approximately 2.9% of the ordinary shares issued and outstanding.
Item 5.
Ownership of 5 Percent or Less of a Class.
Ownership of 5 percent or less of a class
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.
TAA, the general partner of TCOM II, has the power to direct the affairs of TCOM II, including directing the receipt of dividends from, or the proceeds from the sale of, the shares of Common Stock directly owned by TCOM II. Mr. Gendell is the Managing Member of TAA and in that capacity directs its operations.
TM, the general partner of TFP, has the power to direct the affairs of TFP, including directing the receipt of dividends from, or the proceeds from the sale of, the shares of Common Stock directly owned by TFP. Mr. Gendell is the Managing Member of TM and in that capacity directs its operations.
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not Applicable
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Tontine Asset Associates, LLC
Signature:
Jeffrey L. Gendell
Name/Title:
Managing Member
Date:
02/06/2026
Tontine Capital Overseas Master Fund II, L.P.
Signature:
Jeffrey L. Gendell
Name/Title:
Managing Member of Tontine Asset Associates, LLC, the general partner of Tontine Capital Overseas Master Fund II, L.P.
What does the latest Schedule 13G/A filing report for Avadel (AVDL)?
The filing reports that entities associated with Jeffrey L. Gendell now beneficially own 4,839,357 Avadel American Depositary Shares, representing 4.9% of the company’s ordinary shares. The amendment is described as an exit filing because their beneficial ownership has fallen below the 5% reporting threshold.
How many Avadel (AVDL) shares does Jeffrey L. Gendell beneficially own?
Jeffrey L. Gendell reports beneficial ownership of 4,839,357 Avadel American Depositary Shares, equal to 4.9% of the ordinary shares outstanding. This total includes shares directly owned by him and shares held through investment entities for which he serves as managing member or general partner representative.
What stake in Avadel (AVDL) is held by Tontine Capital Overseas Master Fund II, L.P.?
Tontine Capital Overseas Master Fund II, L.P. beneficially owns 2,859,475 Avadel American Depositary Shares, representing approximately 2.9% of the company’s ordinary shares. Tontine Asset Associates, LLC, as its general partner, reports the same number of shares with shared voting and dispositive power over this position.
Why is this Avadel (AVDL) Schedule 13G/A called an exit filing?
The amendment is described as an exit filing because the reporting persons state they no longer beneficially own more than five percent of Avadel’s outstanding ordinary shares. Their reported beneficial ownership is now 4.9%, below the 5% threshold that typically triggers Schedule 13D or 13G reporting.
What ownership powers does Jeffrey L. Gendell report over Avadel (AVDL) shares?
Jeffrey L. Gendell reports sole voting and dispositive power over 70,000 Avadel American Depositary Shares and shared voting and dispositive power over 4,769,357 shares. Together, these positions total 4,839,357 shares, corresponding to 4.9% of Avadel’s outstanding ordinary shares.
On what share count is the Avadel (AVDL) ownership percentage based?
The reported ownership percentages are calculated using 98,153,471 Avadel ordinary shares outstanding as of November 25, 2025. This share count comes from the company’s definitive proxy statement filed on December 3, 2025, and is used to derive the 4.9% and 2.9% ownership figures disclosed.
